Browsing: Moderna

• 20 investments  in manufacturing, ICT, energy, health and agri-business have been signed in past two months.
• Latest Kenya-US trade ties place the East African country at a pole position on attracting more American dollars.
• Since President William Ruto took office in September 2022, Kenya-US engagements have been on a full throttle.

Deepening Kenya-US trade ties have started to pay dividends as American firms move to invest in East Africa’s largest economy. With modern infrastructure, and skilled labour force, Kenya offers one of the best opportunities for US investors eyeing the region.

Currently, Kenya is the second most preferred destination by Americans seeking to invest in Africa. The 2023 US government review shows Kenya hosts 142 American firms while Nigeria has 195 conglomerates.

Latest developments, however, place Kenya at a pole position in attracting more American investors in the short to medium-term.

Deepening Kenya-US bilateral ties

Since President William Ruto took …

Stavros Nicolaou, a Senior Executive at Aspen Pharmacare Group said in the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products.

“The continent would lose its only existing COVID vaccine manufacturing capacity, It would be a massive setback for Africa’s plans to localize and reduce its dependency on imported vaccines,” he said.

John Nkengasong, director of the Africa Centres for Disease Control and Prevention, said global health security would be undermined if companies like Aspen were not backed.…

• Moderna has announced plans to build a manufacturing facility in Kenya
• The firm’s CEO, Stéphane Bancel, said the ‘mRNA’ facility would produce up to 500 million doses of vaccines each year
• Kenyan President Uhuru Kenyatta witnessed the signing of a memorandum of understanding between Kenya and the company to establish the first mRNA manufacturing facility in Africa

American pharmaceutical and biotechnology company Moderna has announced plans to build a manufacturing facility in Kenya.

On Monday, March 7, 2022, Kenyan president Uhuru Kenyatta witnessed the signing of a memorandum of understanding between Kenya and the company to establish the first mRNA manufacturing facility in Africa.

The firm’s CEO, Stéphane Bancel, said the ‘mRNA’ facility would produce up to 500 million doses of vaccines each year.

The company said it would invest up to $500 million in the new facility, which will focus on drug substance manufacturing on the continent of Africa …